In cancer research, dPCR is utilized for a variety of applications, including the detection of circulating tumor DNA (ctDNA) in blood samples, measuring gene expression levels, and identifying genetic mutations that drive cancer progression. The high sensitivity of dPCR makes it particularly useful in detecting minimal residual disease (MRD) and monitoring treatment response in cancer patients.
